Today's pre-market stock movers: SNAP, FB, GOOG, TWTR and more

• $SpringWorks Therapeutics(SWTX.US)$ +19.2% (Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase3DeFi Trial )

• $Roivant Sciences(ROIV.US)$ +7.1% (FDA has approved VTAMA (tapinarof) cream)

• $Ocugen(OCGN.US)$ +5.9% (announces that it is diversifying its innovative pipeline by introducing a Phase 3 cell therapy platform technology called Ne?Cart)

• $Skyline(SKY.US)$ +4.4% (In reaction to earnings）

• $NetEase(NTES.US)$ +4.1% (In reaction to earnings）

• $Euroseas(ESEA.US)$ +3.4% (reinstates dividend first time since 2013; also approves $20 mln share repurchase auth reports earnings)

• $BellRing Brands(BRBR.US)$ +1.1% (authorizes new $50 mln share repurchase program)

• $Marqeta(MQ.US)$ +2.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley)

• $Snap Inc(SNAP.US)$ -29.2% (lowers guidance)

• $INmune Bio(INMB.US)$ -28.5% (FDA places IND application to initiate Phase 2 trial of XPro in patients with Alzheimer's on clinical hold; FDA佗uquests more Info on manufacturing process)

• $Abercrombie & Fitch(ANF.US)$ -19.6% (In reaction to earnings）

• $Pinterest(PINS.US)$ -12.7% (in sympathy with weakSNAPguidance)

• $The Trade Desk(TTD.US)$ -8.6% (in sympathy with weak SNAP guidance)

• $Meta Platforms(FB.US)$ -7% (In sympathy with weak SNAP guidance)

• $Magnite(MGNI.US)$ -5 6% (in sympathy with weak SNAP guidance)

• $Roku Inc(ROKU.US)$ -5.4% (in sympathy with weak SNAP guidance)

• $Rigel Pharmaceuticals(RIGL.US)$ -4.5% (Knight Therapeutics enters Into exclusive license and supply agreements with Rigel Pharmaceuticals to com mere alize fostamatinib in Latin America)

• $Alphabet-C(GOOG.US)$ -3.7% (in sympathy with weak SNAP guidance)

• $Twitter (Delisted)(TWTR.US)$ -3.3% (In sympathy with weak SNAP guidance)

• $Pubmatic(PUBM.US)$ -3.2% (in sympathy with weak SNAP guidance)

• $Holly Energy(HEP.US)$ -3.1% (files for $2 bln mixed securities shelf offering; also files for 59630030 common unit offering by selling shareholders)

• $ARK Innovation ETF(ARKK.US)$ -2.5%(in sympathy with strong ZM earnings)

• $Roblox(RBLX.US)$ -5% (downgraded to Neutral from Overweight at Atlantic Equities)